Research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE stock opened at $0.00 on Monday. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $2.47. The firm has a market capitalization of $2,383.50, a P/E ratio of 0.00 and a beta of 3.71. The company’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Basic Materials Stocks Investing
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
